These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9321537)

  • 1. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 2. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China.
    Wang ZY; Sun GL; Lu JX; Gu LJ; Huang ME; Chen SR
    Nouv Rev Fr Hematol (1978); 1990; 32(1):34-6. PubMed ID: 2349080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Tallman MS; Manji GA
    Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
    Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
    Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
    Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
    Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current therapy of acute promyelocytic leukemia using vitamin A derivatives].
    Löwenberg B; Budel LM
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):796-8. PubMed ID: 8487880
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
    Sun GL
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of pediatric acute promyelocytic leukemia.
    Ribeiro R
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
    [No Abstract]   [Full Text] [Related]  

  • 20. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.